Protara Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences ...
Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of ...
Frontiers6 天
A novel nanobody-based HER2-targeting antibody exhibits potent synergistic antitumor ...
Human epithelial growth factor receptor-2 (HER2) plays an oncogenic role in numerous tumors, including breast, gastric, and various other solid tumors. While anti-HER2 therapies are approved for the ...